This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Multicentric Study Comparing Carcinological and Functional Results of Surgery (PROPENLAP)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2008 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00502723
First received: July 17, 2007
Last updated: July 27, 2012
Last verified: January 2008
  Purpose
National multicentric prospective open study, comparing two current surgical methods: laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.

Condition Intervention Phase
Cancer of the PROSTATE Procedure: Radical retropubic prostatectomy Procedure: Radical laparoscopy prostatectomy Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Prostate Cancer: Multicentric Study Comparing Carcinological and Functional Results of Surgery

Resource links provided by NLM:


Further study details as provided by Assistance Publique - Hôpitaux de Paris:

Primary Outcome Measures:
  • laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer. [ Time Frame: during the study ]

Secondary Outcome Measures:
  • Carcinological (percentage of positive surgical margins, percentage of capsular crossing). [ Time Frame: after the surgical ]
  • Functional (urinary continence, sexuality, quality of life) [ Time Frame: at 2 years ]
  • per and post operational morbidity [ Time Frame: during the 36 months ]
  • economic [ Time Frame: duration and cost of hospitalization ]

Estimated Enrollment: 1440
Study Start Date: December 2007
Estimated Study Completion Date: July 2012
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: 2
Radical laparoscopy prostatectomy
Procedure: Radical laparoscopy prostatectomy
Radical laparoscopy prostatectomy
Experimental: 1
Radical retropubic prostatectomy
Procedure: Radical retropubic prostatectomy
Radical retropubic prostatectomy

Detailed Description:
The aim of this study is to show that radical prostatectomy by laparoscopic way could obtain carcinological results not lower than theses with radical retropubic surgery.
  Eligibility

Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Male, old patient of less than 70 years,
  • having a prostate cancer proven histologically, requiring a radical prostatectomy.
  • Clinical stage T1c and rate of PSA (with 20 ng/ml).
  • Osseous scintiscanning and abdomen-pelvic scanner negative.
  • Patient informed of the study and its participation.
  • Patient affiliated to a social security system.

Exclusion Criteria:

  • Contra-indication with the surgery or the anaesthesia.
  • Antecedent of prostate resection or adenomectomy.
  • Antecedent of inguinal hernia treatment.
  • Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism
  • Patient privatized of freedom.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00502723

Contacts
Contact: Claude ABBOU, PU-PH 33 (0)1.49.81.25.51 claude.abbou@hmn.aphp.fr

Locations
France
Groupe Hospitalier Albert Chenevier Henri Mondor Recruiting
Creteil, France, 94000
Contact: Claude ABBOU, PU-PH    +33 (0)1.49.81.25.51    claude.abbou@hmn.aphp.fr   
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: Claude ABBOU, PU-PH Assistance Publique - Hôpitaux de Paris
  More Information

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT00502723     History of Changes
Other Study ID Numbers: K060402
Study First Received: July 17, 2007
Last Updated: July 27, 2012

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Retropubic Prostatectomy
Surgical Procedures
Laparoscopic

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on August 23, 2017